Comparison

Seviteronel European Partner

Item no. TMO-T13312L-1ml
Manufacturer TargetMol
CASRN 1610537-15-9
Amount 1 mL
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C18H17F4N3O3
Smiles CC(C)[C@@](O)(c1c[nH]nn1)c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias VT-464
Shipping Condition Cool pack
Available
Manufacturer - Targets
Cytochromes P450|||Androgen Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
399.34
Description
Seviteronel (VT-464) is a novel CYP17 cleavage enzyme inhibitor and androgen receptor antagonist used in breast and prostate cancer research.
Pathways
Metabolism|||Endocrinology/Hormones
Bioactivity
Seviteronel is an effective CYP17 lyase inhibitor (h-Lyase IC50=69 nM). In a hamster model of androgen biosynthesis inhibition, it demonstrated both exceptional in vitro lyase/hydroxylase selectivity (~10-fold) and oral activity.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close